International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Bone Marker Standards (WG-BMS) has evaluated the clinical potential of bone turnover markers (BTMs) in the prediction of fracture risk and for monito...

Detaylı Bibliyografya
Asıl Yazarlar:	Vasikaran, S, Cooper, C, Eastell, R, Griesmacher, A, Morris, H, Trenti, T, Kanis, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2011

Benzer Materyaller

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
Yazar:: Vasikaran, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
Yazar:: Vasikaran, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Recommendations for bone marker standards in osteoporosis: what, why and where to now?
Yazar:: Vasikaran, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Standardising biochemical assessment of bone turnover in osteoporosis.
Yazar:: Vasikaran, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
Yazar:: Delmas, P, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
Yazar:: Ström, O, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The International Osteoporosis Foundation: history, objectives and achievements.
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
Yazar:: Diez-Perez, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.
Yazar:: Lips, P, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

DIAGNOSIS OF OSTEOPOROSIS
Yazar:: JOHN A Kanis
Baskı/Yayın Bilgisi: (2016-12-01)

Treatment failure in osteoporosis.
Yazar:: Diez-Perez, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

The Asia-Pacific Regional Audit-Epidemiology, costs, and burden of osteoporosis in India 2013: A report of International Osteoporosis Foundation
Yazar:: Ambrish Mithal, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

National Osteoporosis Foundation of South Africa osteoporosis guideline
Yazar:: J. van Schoor
Baskı/Yayın Bilgisi: (2011-10-01)

The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
Yazar:: Harvey, N, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Comparison of the European and USA practice guidelines for Osteoporosis.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis
Yazar:: T. Songpatanasilp, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01)

Analysis of Molecular Genetic Markers of Osteoporosis in Residents of the Russian Federation
Yazar:: R. V. Polibin, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.
Yazar:: Lips, P, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Foundations of chemistry in the laboratory /
Yazar:: 370910 Hein, Morris, ve diğerleri
Baskı/Yayın Bilgisi: (1986)

Modelling cost-effectiveness in osteoporosis
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.
Yazar:: Hans, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice
Yazar:: Hans, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Programming of osteoporosis and impact on osteoporosis risk.
Yazar:: Dennison, E, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Modern Laboratory Diagnosis of Osteoporosis
Yazar:: Zh.A. Klimova, ve diğerleri
Baskı/Yayın Bilgisi: (2014-10-01)

Osteoporosis.
Yazar:: Sambrook, P, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

A meta-analysis of reference markers of bone turnover for prediction of fracture
Yazar:: Johansson, H, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

The Asian Federation of Osteoporosis Societies' call to action to improve the undertreatment of osteoporosis in Asia
Yazar:: Swan Sim Yeap
Baskı/Yayın Bilgisi: (2017-12-01)

Antidepressant medications and osteoporosis
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Osteoporosis epidemiology in UK Biobank: a unique opportunity for international researchers.
Yazar:: Harvey, N, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The cost-effectiveness of alendronate in the management of osteoporosis.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

A reappraisal of generic bisphosphonates in osteoporosis.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Osteoporosis in the Russian Federation: Problems and Perspectives
Yazar:: Olga Mikhailovna Lesnyak, ve diğerleri
Baskı/Yayın Bilgisi: (2010-10-01)

Biochemical Markers of Bone Resorption Compared with Estimates of Bone Resorption from Radiotracer Kinetic Studies in Osteoporosis
Yazar:: Eastell, R, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Treatment of osteoporosis in men.
Yazar:: Kaufman, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)